Inovio initiates dosing in phase Ib study of INO-4500 vaccine against Lassa Fever in West Africa Feb. 24, 2021
Novel COVID-19 MATE program candidate effectively neutralizes multiple strains of SARS-CoV-2 Feb. 24, 2021
Amyris announces promising preclinical data for its novel COVID-19 RNA vaccine platform Feb. 24, 2021
FDA grants clearance to proceed with clinical testing of tempol as treatment of COVID-19 Feb. 23, 2021
TATX-03 PolyTope monoclonal antibody cocktail shows efficacy in hamster model of COVID-19 Feb. 23, 2021
Sanofi and GSK study adjuvanted recombinant protein-based COVID-19 vaccine candidate in phase II Feb. 22, 2021